Rebecca Madley-Wright04.01.04
Pain is unfortunately a part of daily life for several consumers, mostly manifesting itself in the form of migraine headaches, joint pain and low back pain. In its many forms, pain is often debilitating and results in lost wages and quality of life. In addition, pain costs the American public several billion dollars a year.
The National Pain Foundation, Englewood, CO, says that 40 million Americans suffer from arthritis, another 45 million suffer from headaches (migraines included) and that at any given time, 1% of the U.S. population is temporarily disabled by back pain.
Several pain relieving (analgesics) and anti-inflammatory products are designed to inhibit the production of chemicals that cause pain. Often discussed are the prostaglandins, which is the group of chemicals targeted by nonsteriodal anti-inflammatory (NSAIDS) drugs like aspirin and ibuprofen. In recent years NSAIDS have fallen out of favor with the medical community due to the prevalence of side effects. In addition, according to Nature's Pain Killers by Carl Germano and William Cabot, "These pain relievers inhibit a key enzyme in pros
The National Pain Foundation, Englewood, CO, says that 40 million Americans suffer from arthritis, another 45 million suffer from headaches (migraines included) and that at any given time, 1% of the U.S. population is temporarily disabled by back pain.
Indication Areas
Several pain relieving (analgesics) and anti-inflammatory products are designed to inhibit the production of chemicals that cause pain. Often discussed are the prostaglandins, which is the group of chemicals targeted by nonsteriodal anti-inflammatory (NSAIDS) drugs like aspirin and ibuprofen. In recent years NSAIDS have fallen out of favor with the medical community due to the prevalence of side effects. In addition, according to Nature's Pain Killers by Carl Germano and William Cabot, "These pain relievers inhibit a key enzyme in pros
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
